Financials
- Market Capitalization 1.43 B
- Employee 145
- Founded 2024
- CEO N/A
- Website www.kailera.com
- Headquarter Delaware, United States
- FIGI BBG01Q3NQQJ1
- Industry N/A
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2164 | DMRA Damora Therapeutics, Inc. Ordinary Shares | 23.22 USD | -4.44% | +6.12% | +8.25% | -17.07% | 1.44 B USD | ||
| 2166 | PONY Pony AI Inc. American Depositary Shares | 3.31 USD | -5.97% | -23.56% | -31.04% | -71.73% | 1.44 B USD | ||
| 2174 | ADRX ADARx Pharmaceuticals, Inc. Common Stock | 12.79 USD | -9.68% | -10.06% | -25.55% | -42.13% | 1.42 B USD | ||
| 2179 | AGLT Agility Robotics, Inc. Common Stock | 5.85 USD | -9.86% | -17.02% | -48.68% | -48.68% | 1.42 B USD |
Frequently asked questions about Kailera Therapeutics, Inc. Common Stock
What is the Kailera Therapeutics, Inc. Common Stock stock price today?
The current price of Kailera Therapeutics, Inc. Common Stock (KLRA) is 11.02. Over the past 24 hours, the stock has changed by -4.84%. Follow the KLRA chart for real-time price dynamics.
What is the stock ticker of Kailera Therapeutics, Inc. Common Stock?
Kailera Therapeutics, Inc. Common Stock trades under the ticker KLRA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kailera Therapeutics, Inc. Common Stock stock going up?
KLRA has changed by -14.64% over the last week, -13.91% over the last month, and -57.62% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kailera Therapeutics, Inc. Common Stock?
Kailera Therapeutics, Inc. Common Stock currently has a market capitalization of 1.43 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kailera Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Kailera Therapeutics, Inc. Common Stock reported earnings of -0.74 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kailera Therapeutics, Inc. Common Stock net income for the last quarter?
Kailera Therapeutics, Inc. Common Stock reported net income of -95.67 M for the last quarter. The previous quarter showed -111.31 M, which means net income changed by +14.05%.
How many employees does Kailera Therapeutics, Inc. Common Stock have?
As of the latest available data, Kailera Therapeutics, Inc. Common Stock has 145 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Kailera Therapeutics, Inc. Common Stock stock?
You can buy Kailera Therapeutics, Inc. Common Stock (KLRA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kailera Therapeutics, Inc. Common Stock stock?
Investing in Kailera Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KLRA chart and related analysis on metatrader.com as part of your research.